Dew, your predictions have been consistantly right and applicable to the past 20 or so conference calls. Why is this one different? 1. We are over a barrel and Cox needs to do something dramatic to restore confidence. 2. We have an approved and maybe even marketed product in the US, this is new (I state the obvious) but may be the thing to bring the next partnership out into the open. My predications will be "out there". They are: a partnership for CD 137 (this based on serious overinterpretation of the remarks in the annual report emphasising the need for tonnage quantities and potential clinical importance, receipt of state funds to further support operations, an update on the malaria vaccine (this based on Dr. Meade's 2007 poster at BIO) and...OK I don't need to dig the hole any deeper. I hope the call will not be as devoid of concrete good stuff you you suggest. The DIC trial? Well probably not yet. Regards, bp
